Daoud S - Search Results

1

Discovery of novel chemotype inhibitors targeting Anaplastic Lymphoma Kinase receptor through ligand-based pharmacophore modelling.

El-Jundi I, Daoud S, Taha MO. El-Jundi I, et al. Among authors: daoud s. SAR QSAR Environ Res. 2024 Sep;35(9):795-815. doi: 10.1080/1062936X.2024.2406398. Epub 2024 Oct 9. SAR QSAR Environ Res. 2024. PMID: 39382553

2

Pharmacophore modeling of JAK1: A target infested with activity-cliffs.

Daoud S, Taha MO. Daoud S, et al. J Mol Graph Model. 2020 Sep;99:107615. doi: 10.1016/j.jmgm.2020.107615. Epub 2020 Apr 21. J Mol Graph Model. 2020. PMID: 32339898

3

Design and Synthesis of New JAK1 Inhibitors based on Sulfonamide- Triazine Conjugates.

Daoud S, Taha MO. Daoud S, et al. Curr Comput Aided Drug Des. 2021;17(7):916-926. doi: 10.2174/1573409916666201224152253. Curr Comput Aided Drug Des. 2021. PMID: 33357183

4

Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti- COVID-19 Treatments.

Daoud S, Taha M. Daoud S, et al. Med Chem. 2022;18(8):871-883. doi: 10.2174/1573406418666220118153541. Med Chem. 2022. PMID: 35040417

5

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning.

Al-Tawil MF, Daoud S, Hatmal MM, Taha MO. Al-Tawil MF, et al. Among authors: daoud s. RSC Adv. 2022 Apr 5;12(17):10686-10700. doi: 10.1039/d2ra00136e. eCollection 2022 Mar 31. RSC Adv. 2022. PMID: 35424985 Free PMC article.

6

Augmenting bioactivity by docking-generated multiple ligand poses to enhance machine learning and pharmacophore modelling: discovery of new TTK inhibitors as case study.

Al-Imam AM, Daoud S, Hatmal MM, Taha MO. Al-Imam AM, et al. Among authors: daoud s. Mol Inform. 2023 Jun;42(6):e2300022. doi: 10.1002/minf.202300022. Epub 2023 Jun 7. Mol Inform. 2023. PMID: 37222400

7

Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes.

Banat R, Daoud S, Taha MO. Banat R, et al. Among authors: daoud s. Mol Divers. 2024 Dec;28(6):4241-4257. doi: 10.1007/s11030-024-10814-y. Epub 2024 Mar 6. Mol Divers. 2024. PMID: 38446372

8

Protein characteristics substantially influence the propensity of activity cliffs among kinase inhibitors.

Daoud S, Taha M. Daoud S, et al. Sci Rep. 2024 Apr 20;14(1):9058. doi: 10.1038/s41598-024-59501-w. Sci Rep. 2024. PMID: 38643174 Free PMC article.

9

Advances in the design and discovery of next-generation janus kinase-2 (JAK2) inhibitors for the treatment of myeloproliferative neoplasms.

Daoud S, Taha MO. Daoud S, et al. Expert Opin Drug Discov. 2024 Dec;19(12):1403-1415. doi: 10.1080/17460441.2024.2417368. Epub 2024 Oct 16. Expert Opin Drug Discov. 2024. PMID: 39410824 Review.

10

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies.

Daoud S, Alabed SJ, Dahabiyeh LA. Daoud S, et al. Acta Pharm. 2021 Jun 1;71(2):163-174. doi: 10.2478/acph-2021-0016. Acta Pharm. 2021. PMID: 33151166 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters